DREAMM 2
Enrolling By Invitation
18 years - 99 years
All
Phase
2
10 participants needed
1 Location
Brief description of study
This research study is being done to learn more about multiple myeloma and if the study drug, GSK2857916, can improve multiple myeloma in patients who have already failed other treatments.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: multiple myeloma
-
Age: 18 years - 99 years
-
Gender: All
Updated on
04 Aug 2024.
Study ID: 830000
If you need assistance finding a non-cancer clinical research study or if you have any questions, please email psom-ocr@pobox.upenn.edu
For Cancer trials contact Penn Medicine's Cancer Trial Navigator at: PMCancerResearch@pennmedicine.upenn.edu or 215-349-8245
